Objective To investigate the effects of polyphyllin Ⅲ on proliferation,cycle and apoptosis of colon cancer cells HCT116;To explore its mechanism in treating colon cancer.Methods Colon cancer cells HCT116 were cultured in vitro,the cells were dived into control group and polyphyllin Ⅲ low-,medium-and high-dosage group,drug-free media and low-,medium-and high-concentration of polyphyllin Ⅲ were applied to the cells.Cell proliferation was detected by CCK-8 method,and cell cycle and apoptosis were detected by flow cytometry,the expressions of cyclinD1,CDK4,CDK6,RB,p-RB,Bax,Bcl-2,Bcl-xl mRNAs and proteins were detected by RT-PCR and Western blot.Results Compared with the control group,the HCT116 cell viability decreased in the polyphyllin Ⅲ groups with different dosages(P<0.01),the proportion of G0-G1 phase cells increased(P<0.01),the proportion of S,G2-M phase cells decreased(P<0.01),the cell apoptosis rate increased(P<0.01),and the expressions of cyclinD1,CDK4,CDK6,Bcl-2,Bcl-xl mRNA and cyclinD1,CDK4,CDK6,p-RB,Bcl-2,Bcl-xl proteins decreased,while the expression of Bax mRNA and protein increased,with a dosage-dependent manner(P<0.05,P<0.01).Conclusion Polyphyllin Ⅲ can inhibit the proliferation of colon cancer cells cultured in vitro and promote cell apoptosis,blocking cells in the G0-G1 phase.The mechanism may be related to the inhibition of cell cycle related proteins and apoptosis related protein expression.

The symptom science model identifies complex symptoms and measures their phenotypic characteristics.It provides an in-depth analysis of symptom behaviors and biological mechanisms,aiding healthcare professionals in early symptom detection and initiating appropriate diagnostic and treatment measures.The model supports personalized interventions,aiming to achieve precision care and ultimately improve patient health.This study reviews the development and scope of the symptom science model,analyzes its current applications in chronic kidney disease,and explores its implications for symptom management in this condition.The aim is to offer insights and references for the scientific management of chronic kidney disease symptoms.

Objective:To explore the effects of nutritional therapy based on indirect calorimetry in patients with extremely severe burns during hypermetabolic stage.Methods:This study was a retrospective cohort study. From March 25, 2022 to March 30, 2024, 20 extremely severe burn patients who met the inclusion criteria were admitted to the Department of Burn and Wound Repair of the Second Affiliated Hospital of Zhejiang University School of Medicine. There were 15 males and 5 females, aged (46±12) years. The patients were divided into death group (6 cases) and survival group (14 cases) according to their treatment outcomes. At the 3 rd, 7 th, 14 th, and 21 st d after injury, the resting energy expenditure (REE) of patients in the two groups was measured by indirect calorimetry once a day, and the nutritional treatment scheme was formulated according to the results of REE. The REE value, levels of albumin and interleukin-6 (IL-6), actual energy intake, and enteral nutrition energy intake of patients in the two groups at the 3 rd, 7 th, 14 th, and 21 st d after injury were collected (the last two indicators were respectively expressed as the mean values of the 3 rd to 6 th, 7 th to 10 th, 14 th to 17 th, and 21 st to 24 th d after injury). The actual energy intake/REE value and enteral nutrition energy intake/actual energy intake were calculated. Results:The REE values of patients in survival group and death group were (8 143±2 328), (9 843±2 610), (10 149±2 248), (9 608±2 838) kJ and (6 816±2 057), (10 691±2 515), (11 031±2 850), (8 990±2 018) kJ, respectively at the 3 rd , 7 th, 14 th, and 21 st d after injury. The REE value and enteral nutrition energy intake of patients in the two groups showed trends of increase first and decrease then from the 3 rd to 21 st d after injury, while the differences in the above two indicators at each time point between the two groups of patients were not statistically significant ( P>0.05). The actual energy intake of patients in survival group at the 21 st d after injury was significantly higher than that at the 3 rd d after injury ( P<0.05), and the enteral nutrition energy intake of patients in death group at the 14 th d after injury was significantly higher than that at the 3 rd d after injury ( P<0.05). There were no statistically significant differences in overall comparison in actual energy intake/REE value and enteral nutrition energy intake/actual energy intake at each time point after injury between and within the two groups of patients ( P>0.05). The level of IL-6 of patients in survival group at the 21 st d after injury was significantly lower than that at the 3 rd and 7 th d after injury, respectively (with both P values <0.05), and significantly higher than that at the 14 th d after injury ( P<0.05); the level of IL-6 of patients in death group at the 21 st d after injury was significantly higher than that at the 3 rd, 7 th, and 14 th d after injury (with P values all <0.05). The albumin level of patients in survival group at the 7 th d after injury was significantly higher than that at the 3 rd d after injury ( P<0.05). Conclusions:The REE value and enteral nutrition energy intake of extremely severe burn patients showed trends of increase first and decrease then, while they have no significant effects on the clinical outcome of the patients. The nutritional treatment scheme based on the indirect calorimetry can basically meet the energy demand of patients with extremely severe burns during hypermetabolic stage. The impacts of the albumin and IL-6 levels on the clinical outcome of extremely severe burn patients still need further research.

OBJECTIVE To provide standardized whole-process guidance on drug traceability codes for medical institutions in Sichuan province， ensuring medication safety and compliance with medical insurance supervision requirements. METHODS Based on evidence-based principles and expert consensus， Expert Consensus on Whole-process Management of Drug Traceability Codes in Medical Institutions of Sichuan Province （hereinafter referred to as the Consensus） was formulated through systematic literature review， field investigations， establishment of a multidisciplinary expert committee and multiple rounds of questionnare consultation via the modified Delphi method， and finalized through consensus meetings. RESULTS & CONCLUSIONS The Consensus clarifies key operating procedures for code verification， code assignment and code return， whole-process operational standards for drug warehouse acceptance and storage， drug warehouse outbound delivery and pharmacy acceptance check， drug distribution and dispensing in pharmacy and intravenous admixture center， medication administration in nursing units and examination departments， as well as drug return process. Key recommendations are proposed such as improving the core functions of the drug traceability system， unifying the hospital-wide traceability code database， strengthening the management of traceability codes for backup medications， establishing a management organization and institutional framework， and optimizing the architectural design and data governance requirements of the drug traceability system. The release of the Consensus will provide scientific， standardized and implementable practical guidelines for medical institutions of Sichuan province， helping to improve closed-loop management of the drug traceability system， strengthen medication safety and fulfil medical insurance fund supervision.

Tumor microenvironment(TME)includes inflammatory,metabolic,and immune microenvironment,which interact in a complex network,influencing tumorigenesis,progression,and metastasis.Clinical studies on traditional Chinese medicine(TCM)have found that dampness pathogen plays a significant role in gastrointestinal precancerous lesions,tumorigenesis,and metastasis.It disrupts the gastrointestinal tumor's inflammatory,metabolic,and immune microenvironments,promoting tumor development through various mechanisms.Based on the theory of dampness pathogen,it is proposed to eliminate dampness combined with detoxification to regulate tumor inflammatory microenvironment;invigorate qi,warm yang,and remove dampness to regulate metabolic microenvironment;and strengthen the spleen,support vital energy,and dispel dampness to improve immunosuppressive microenvironment.Treating gastrointestinal tumors from the perspective of dampness pathogen theory can offer new insights and focus areas for clinical diagnosis and treatment,as well as directions for research into the molecular mechanisms of compound Chinese herbal formulas.

Objective Key genes related to ferroptosis in asthma were screened using bioinformatics,and their molecular mechanisms of action in the development of asthma were investigated.Methods Data sets related to asthma were obtained from the GEO database,and ferroptosis-related genes in FerrDB were downloaded to screen differentially expressed genes related to ferroptosis in asthma.LASSO regression and SVM-RFE algorithm were used to further screen the core genes.Molecular biology verification of these screened genes was performed,and miRNA microarray data from asthmatic mice combined with miRWalk and TargetScan were used to predict the upstream miRNA.Results From GSE43696,212 differentially expressed genes with consistent phenotypes in moderate-to-severe asthma were screened,including five ferroptosis-related genes:HCAR1,NOS2,MEF2C,IL6 and NOX1.The SVM-RFE results indicate that MEF2C has the greatest impact on the model.Experimental validation showed that the expression of both its mRNA and protein products was downregulated in asthmatic mice and was primarily expressed in the airway epithelium as well as within the cell nucleus.The prediction analysis results of miRNA targeting MEF2C revealed that miR-2861,which is upregulated in asthmatic mice,may target MEF2C,and that the expression of miR-2861 was significantly downregulated after IL-17A knockout.Conclusion MEF2C is a key regulator in ferropto-sis-related asthma.Its down regulation may be associated with IL-17A-mediated upregulation of miR-2861.

The symptom science model identifies complex symptoms and measures their phenotypic characteristics.It provides an in-depth analysis of symptom behaviors and biological mechanisms,aiding healthcare professionals in early symptom detection and initiating appropriate diagnostic and treatment measures.The model supports personalized interventions,aiming to achieve precision care and ultimately improve patient health.This study reviews the development and scope of the symptom science model,analyzes its current applications in chronic kidney disease,and explores its implications for symptom management in this condition.The aim is to offer insights and references for the scientific management of chronic kidney disease symptoms.

Tumor microenvironment(TME)includes inflammatory,metabolic,and immune microenvironment,which interact in a complex network,influencing tumorigenesis,progression,and metastasis.Clinical studies on traditional Chinese medicine(TCM)have found that dampness pathogen plays a significant role in gastrointestinal precancerous lesions,tumorigenesis,and metastasis.It disrupts the gastrointestinal tumor's inflammatory,metabolic,and immune microenvironments,promoting tumor development through various mechanisms.Based on the theory of dampness pathogen,it is proposed to eliminate dampness combined with detoxification to regulate tumor inflammatory microenvironment;invigorate qi,warm yang,and remove dampness to regulate metabolic microenvironment;and strengthen the spleen,support vital energy,and dispel dampness to improve immunosuppressive microenvironment.Treating gastrointestinal tumors from the perspective of dampness pathogen theory can offer new insights and focus areas for clinical diagnosis and treatment,as well as directions for research into the molecular mechanisms of compound Chinese herbal formulas.

Objective To investigate the effects of polyphyllin Ⅲ on proliferation,cycle and apoptosis of colon cancer cells HCT116;To explore its mechanism in treating colon cancer.Methods Colon cancer cells HCT116 were cultured in vitro,the cells were dived into control group and polyphyllin Ⅲ low-,medium-and high-dosage group,drug-free media and low-,medium-and high-concentration of polyphyllin Ⅲ were applied to the cells.Cell proliferation was detected by CCK-8 method,and cell cycle and apoptosis were detected by flow cytometry,the expressions of cyclinD1,CDK4,CDK6,RB,p-RB,Bax,Bcl-2,Bcl-xl mRNAs and proteins were detected by RT-PCR and Western blot.Results Compared with the control group,the HCT116 cell viability decreased in the polyphyllin Ⅲ groups with different dosages(P<0.01),the proportion of G0-G1 phase cells increased(P<0.01),the proportion of S,G2-M phase cells decreased(P<0.01),the cell apoptosis rate increased(P<0.01),and the expressions of cyclinD1,CDK4,CDK6,Bcl-2,Bcl-xl mRNA and cyclinD1,CDK4,CDK6,p-RB,Bcl-2,Bcl-xl proteins decreased,while the expression of Bax mRNA and protein increased,with a dosage-dependent manner(P<0.05,P<0.01).Conclusion Polyphyllin Ⅲ can inhibit the proliferation of colon cancer cells cultured in vitro and promote cell apoptosis,blocking cells in the G0-G1 phase.The mechanism may be related to the inhibition of cell cycle related proteins and apoptosis related protein expression.

Objective Key genes related to ferroptosis in asthma were screened using bioinformatics,and their molecular mechanisms of action in the development of asthma were investigated.Methods Data sets related to asthma were obtained from the GEO database,and ferroptosis-related genes in FerrDB were downloaded to screen differentially expressed genes related to ferroptosis in asthma.LASSO regression and SVM-RFE algorithm were used to further screen the core genes.Molecular biology verification of these screened genes was performed,and miRNA microarray data from asthmatic mice combined with miRWalk and TargetScan were used to predict the upstream miRNA.Results From GSE43696,212 differentially expressed genes with consistent phenotypes in moderate-to-severe asthma were screened,including five ferroptosis-related genes:HCAR1,NOS2,MEF2C,IL6 and NOX1.The SVM-RFE results indicate that MEF2C has the greatest impact on the model.Experimental validation showed that the expression of both its mRNA and protein products was downregulated in asthmatic mice and was primarily expressed in the airway epithelium as well as within the cell nucleus.The prediction analysis results of miRNA targeting MEF2C revealed that miR-2861,which is upregulated in asthmatic mice,may target MEF2C,and that the expression of miR-2861 was significantly downregulated after IL-17A knockout.Conclusion MEF2C is a key regulator in ferropto-sis-related asthma.Its down regulation may be associated with IL-17A-mediated upregulation of miR-2861.